Home | A method of prognosing and stratifying treatment of glioma based on transcriptional activation of immunomodulating endogenous retroviruses (ERVs) in tumor microenvironment (TME)
Diagnostics
A method of prognosing and stratifying treatment of glioma based on transcriptional activation of immunomodulating endogenous retroviruses (ERVs) in tumor microenvironment (TME)
Patent inventors: Dąbrowski Michał, Kamińska-Kaczmarek Bożena, Maleszewska-Bobińska Marta, Mondal Shamba, Wojtas Bartosz
A description of the invention will be available after the patent application is published.
Nencki Institute is the sole applicant.
For more information contact Technology Transfer Office.
Application number:
EP22198465.1 (28.09.2022)
Patent status:
pending